EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Activation of Gcn2 by small molecules designed to be inhibitors

Kenneth R Carlson, Millie M Georgiadis, Feven Tameire, Kirk A Staschke, Ronald C Wek

Journal of Biological Chemistry · 2023-04 · 299 (4) · 104595

DOI: 10.1016/j.jbc.2023.104595 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023-04. Verfasst von Kenneth R Carlson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Eukaryotic Initiation Factor-2, Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The integrated stress response (ISR) is an important mechanism by which cells confer protection against environmental stresses. Central to the ISR is a collection of related protein kinases that monitor stress conditions, such as Gcn2 (EIF2AK4) that recognizes nutrient limitations, inducing phosphorylation of eukaryotic translation initiation factor 2 (eIF2). Gcn2 phosphorylation of eIF2 lowers bulk protein synthesis, conserving energy and nutrients, coincident with preferential translation of stress-adaptive gene transcripts, such as that encoding the Atf4 transcriptional regulator. While Gcn2 is central for cell protection to nutrient stress and its depletion in humans leads to pulmonary disorders, Gcn2 can also contribute to the progression of cancers and facilitate neurological disorders during chronic stress. Consequently, specific ATP-competitive inhibitors of Gcn2 protein kinase have been developed. In this study, we report that one such Gcn2 inhibitor, Gcn2iB, can activate Gcn2, and we probe the mechanism by which this activation occurs. Low concentrations of Gcn2iB increase Gcn2 phosphorylation of eIF2 and enhance Atf4 expression and activity. Of importance, Gcn2iB can activate Gcn2 mutants devoid of functional regulatory domains or with certain kinase domain substitutions derived from Gcn2-deficient human patients. Other ATP-competitive inhibitors can also activate Gcn2, although there are differences in their mechanisms of activation. These results provide a cautionary note about the pharmacodynamics of eIF2 kinase inhibitors in therapeutic applications. Compounds designed to be kinase inhibitors that instead directly activate Gcn2, even loss of function variants, may provide tools to alleviate deficiencies in Gcn2 and other regulators of the ISR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eukaryotic Initiation Factor-2Protein Serine-Threonine KinasesHumansAdenosine TriphosphateEnzyme ActivationPhosphorylationProtein Kinase InhibitorsProtein KinasesSulfonamides

Stichwörter der Autor:innen

Gcn2eIF2 kinaseeIF2 phosphorylationintegrated stress response

Substanzen

Adenosine TriphosphateEukaryotic Initiation Factor-2Protein Kinase InhibitorsProtein KinasesProtein Serine-Threonine KinasesEIF2AK4 protein, humanGcn2iBSulfonamides

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA.
  • HiberCell, Inc, New York, New York, USA.
  • Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA. Elec…

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health
  • National Institute of General Medical Sciences
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Carlson, K. R., Georgiadis, M. M., Tameire, F., Staschke, K. A., & Wek, R. C. (2023). Activation of Gcn2 by small molecules designed to be inhibitors. Journal of Biological Chemistry, 299(4), 104595. https://doi.org/10.1016/j.jbc.2023.104595

Vancouver

Carlson KR, Georgiadis MM, Tameire F, Staschke KA, Wek RC. Activation of Gcn2 by small molecules designed to be inhibitors. Journal of Biological Chemistry. 2023;299(4):104595. doi:10.1016/j.jbc.2023.104595

BibTeX
@article{Carlson2023,
  author = {Carlson, Kenneth R and Georgiadis, Millie M and Tameire, Feven and Staschke, Kirk A and Wek, Ronald C},
  title = {Activation of Gcn2 by small molecules designed to be inhibitors},
  journal = {Journal of Biological Chemistry},
  year = {2023},
  volume = {299},
  number = {4},
  pages = {104595},
  doi = {10.1016/j.jbc.2023.104595}
}
Kostenlos starten →